心拍管理装置の世界市場：動向、予測、競合分析（～2030年）

心拍管理装置の動向と予測

世界の心拍管理装置の市場規模は、2024～2030年にかけてCAGR 4.5%で成長し、2030年までに約193億米ドルに達すると予測されています。この市場の主な促進要因は、心血管疾患の有病率の上昇、心拍管理装置の利点に対する意識の高まり、継続的な技術の進歩により、より効果的で侵襲性の低い新しい革新的な装置が開発されていることです。世界の心拍管理装置市場の将来は、病院・診療所および外来手術センター市場における機会によって有望視されています。

心拍管理装置市場の洞察

Lucintelは、院外心停止の有病率の上昇により、除細動器が予測期間中最大のセグメントであり続けると予測しています。

この市場の中では、病院と診療所が最大のセグメントであり続けると予測されます。

北米は、高齢者人口の急増と高度なヘルスケアシステムの存在により、引き続き最大地域となります。

市場規模・推計：心拍管理装置の市場規模を金額（10億米ドル）で推計

動向と予測分析：各種セグメント別、地域別の市場動向（2018～2023年）と予測（2024～2030年）

セグメント別分析：製品タイプ別、最終用途別、地域別の心拍管理装置の市場規模を金額（10億米ドル）で推計

地域別分析：心拍管理装置市場の北米、欧州、アジア太平洋、その他の地域の内訳

成長機会：心拍管理装置市場の製品タイプ、最終用途、地域別の成長機会分析

戦略分析：心拍管理装置市場のM&A、新製品開発、競合情勢などが含まれます

ポーターのファイブフォースモデルに基づく業界の競合強度分析

本レポートは以下の11の主要な質問に回答しています：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の心拍管理装置市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析：2018～2030年

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の心拍管理装置市場の動向（2018～2023年）と予測（2024～2030年）
• 世界の心拍管理装置市場：製品タイプ別
  • 心臓ペースメーカー
  • 除細動器
  • 心臓再同期治療装置
• 世界の心拍管理装置市場：最終用途別
  • 病院・クリニック
  • 外来手術センター
  • その他

第4章 市場動向と予測分析：地域別（2018～2030年）

• 世界の心拍管理装置市場：地域別
• 北米の心拍管理装置市場
• 欧州の心拍管理装置市場
• アジア太平洋の心拍管理装置市場
• その他の地域の心拍管理装置市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品タイプ別の世界の心拍管理装置市場の成長機会
  • 最終用途別の世界の心拍管理装置市場の成長機会
  • 地域別の世界の心拍管理装置市場の成長機会
• 世界の心拍管理装置市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の心拍管理装置市場の能力拡大
  • 世界の心拍管理装置市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Physio-Control
• Medtronic
• Abbott
• Boston Scientific Corporation
• Schiller
• Koninklijke Philips
• BIOTRONIK
• Progetti
• Zoll Medical Corporation
• LivaNova

Cardiac Rhythm Management Devices Trends and Forecast

The future of the global cardiac rhythm management devices market looks promising with opportunities in the hospital & clinic and ambulatory surgery center markets. The global cardiac rhythm management devices market is expected to reach an estimated $19.3 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are rising prevalence of cardiovascular diseases, growing awareness towards the benefits of cardiac rhythm management devices, and on-going technological advancements are resulting in development of new and innovative devices that are more effective and less invasive.

A more than 150-page report is developed to help in your business decisions.

Cardiac Rhythm Management Devices by Segment

The study includes a forecast for the global cardiac rhythm management devices by product type, end use, and region.

Cardiac Rhythm Management Devices Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Cardiac Pacemakers
• Defibrillators
• Cardiac Resynchronization Therapy Devices

Cardiac Rhythm Management Devices Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others

Cardiac Rhythm Management Devices Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Cardiac Rhythm Management Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cardiac rhythm management devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cardiac rhythm management devices companies profiled in this report include-

• Physio-Control
• Medtronic
• Abbott
• Boston Scientific Corporation
• Schiller
• Koninklijke Philips
• Biotronik
• Progetti
• Zoll Medical Corporation
• Livanova

Cardiac Rhythm Management Devices Market Insights

Lucintel forecasts that defibrillators will remain the largest segment over the forecast period due to the rising prevalence of out-of-hospital cardiac arrests.

Within this market, hospitals and clinics is expected to remain the largest segment.

North America will remain the largest region due to surge in elderly population and presence of advanced healthcare system in the region.

Features of the Global Cardiac Rhythm Management Devices Market

Market Size Estimates: Cardiac rhythm management devices market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cardiac rhythm management devices market size by product type, end use, and region in terms of value ($B).

Regional Analysis: Cardiac rhythm management devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, end uses, and regions for the cardiac rhythm management devices market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cardiac rhythm management devices market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cardiac rhythm management devices market size?

Answer: The global cardiac rhythm management devices market is expected to reach an estimated $19.3 billion by 2030.

Q.2 What is the growth forecast for cardiac rhythm management devices market?

Answer: The global cardiac rhythm management devices market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cardiac rhythm management devices market?

Answer: The major drivers for this market are rising prevalence of cardiovascular diseases, growing awareness towards the benefits of cardiac rhythm management devices, and on-going technological advancements are resulting in development of new and innovative devices that are more effective and less invasive.

Q4. What are the major segments for cardiac rhythm management devices market?

Answer: The future of the cardiac rhythm management devices market looks promising with opportunities in the hospital & clinic and ambulatory surgery center markets.

Q5. Who are the key cardiac rhythm management devices market companies?

Answer: Some of the key cardiac rhythm management devices companies are as follows:

• Physio-Control
• Medtronic
• Abbott
• Boston Scientific Corporation
• Schiller
• Koninklijke Philips
• Biotronik
• Progetti
• Zoll Medical Corporation
• Livanova

Q6. Which cardiac rhythm management devices market segment will be the largest in future?

Answer: Lucintel forecasts that defibrillators will remain the largest segment over the forecast period due to the rising prevalence of out-of-hospital cardiac arrests.

Q7. In cardiac rhythm management devices market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to surge in elderly population and presence of advanced healthcare system in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cardiac rhythm management devices market by product type (cardiac pacemakers, defibrillators, and cardiac resynchronization therapy devices), end use (hospitals & clinics, ambulatory surgery centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cardiac Rhythm Management Devices Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Cardiac Rhythm Management Devices Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Cardiac Rhythm Management Devices Market by Product Type
  • 3.3.1: Cardiac Pacemakers
  • 3.3.2: Defibrillators
  • 3.3.3: Cardiac Resynchronization Therapy Devices
• 3.4: Global Cardiac Rhythm Management Devices Market by End Use
  • 3.4.1: Hospitals & Clinics
  • 3.4.2: Ambulatory Surgery Centers
  • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Cardiac Rhythm Management Devices Market by Region
• 4.2: North American Cardiac Rhythm Management Devices Market
  • 4.2.2: North American Cardiac Rhythm Management Devices Market by End Use: Hospitals & Clinics, Ambulatory Surgery Centers, and Others
• 4.3: European Cardiac Rhythm Management Devices Market
  • 4.3.1: European Cardiac Rhythm Management Devices Market by Product Type: Cardiac Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices
  • 4.3.2: European Cardiac Rhythm Management Devices Market by End Use: Hospitals & Clinics, Ambulatory Surgery Centers, and Others
• 4.4: APAC Cardiac Rhythm Management Devices Market
  • 4.4.1: APAC Cardiac Rhythm Management Devices Market by Product Type: Cardiac Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices
  • 4.4.2: APAC Cardiac Rhythm Management Devices Market by End Use: Hospitals & Clinics, Ambulatory Surgery Centers, and Others
• 4.5: ROW Cardiac Rhythm Management Devices Market
  • 4.5.1: ROW Cardiac Rhythm Management Devices Market by Product Type: Cardiac Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices
  • 4.5.2: ROW Cardiac Rhythm Management Devices Market by End Use: Hospitals & Clinics, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Cardiac Rhythm Management Devices Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Cardiac Rhythm Management Devices Market by End Use
  • 6.1.3: Growth Opportunities for the Global Cardiac Rhythm Management Devices Market by Region
• 6.2: Emerging Trends in the Global Cardiac Rhythm Management Devices Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Cardiac Rhythm Management Devices Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cardiac Rhythm Management Devices Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Physio-Control
• 7.2: Medtronic
• 7.3: Abbott
• 7.4: Boston Scientific Corporation
• 7.5: Schiller
• 7.6: Koninklijke Philips
• 7.7: BIOTRONIK
• 7.8: Progetti
• 7.9: Zoll Medical Corporation
• 7.10: LivaNova